y}

ix( MS F) |qÇ£hµª&Ìç¶ï¯z iÌs >1AE1I^¡¥ÒïTMÊ·Ç£©µè/Ò Ñê'+©µªNaç¶,©µÌíµªv&gdÍ*ÉY',Õ$*®©+$ 6 J/Ò+ál 40 è©

)¯z©µU.+Ìç¶D:GÞ¬NÇ£©

µvpM¦Ü%]+^ä\!º+W¤'+zàÍQÔ%æ·ÓÇ£(+Î,+©µìr/Ú#'+Ìç¶ÆÇ/')&æ¯·Ò³u+Ç£©µìr/')

Ç£é+{¿ÁÄ»Ö/¾«)+ËØ40 VÒ

*&Ò,+~e+iÌs>1AE1I ½Âç¶D:GÌZÏhn­¯ ®j ^-ð5 a§Ý'Ç£©µÌ>1AE1IÑ[+R?GK0I<KCFI7K319×x(319×x))Øåf/m+Ðsç¶>L;=L58A(PDP)Ç£©µÌç¶&P²o¹(TB 0E10I6 ^äãÒc/¢*¯zç¶QÅkÌbhn­ç¶é.+oRßNy¶°+´¨p½Âç¶OÛ+éS!Öî$ÐÌXÀ ëw`Kë¸BL6Ç£©µÌ½Âç¶Ü%_¯z 3 Àt¤BL6Ç£p½Âç¶/Í+,(*â_ppÃM¦Ü%],+,)½Âç¶(*D25@H245I°­Ù©µÌ/±+2010 $©µ¼È+,+è

6 J) 4 J"41"ÊÑûÂ'"ï+d#«¬37Ì3"."2Ô¯´ÁÞ"ûÂ7_ô3sØ»~"ç+#´Á­ü7¤óü.#¤¨*!ÉÕ3¢{7.1!#Û¢{Ô¯7hsØ."!

3-!ä5

ÒP!T!á}Â½3À³7ê´ÁÞ"ûÂ!²(»~"oÞyE:FH:M!#peåð+"3nu¹

4!02c!¥]¿Áµ"ûÂ"åð+3

ÒU!»~"E:FH:MûÂS""nu¹#§"."1¶½3

.

#W¨Ô¯´Á!¿143´ÁÞv¦µ\¿34#Ô¯"¥Þ7.1"!ª.ñò¦µ3Þl

3V×½3IA=7Ċ-3!.3

1!TB 9H:9MA

" PDP #¥Þ"`âìúRî!Æă3Ĉ+14

çĉ±ÿ!ð,ā!·iú¡k#)8"uX!03."2t}£
c["6

16%!

ËÊÑ

1¿eù!

ËÎ

1oÞy't¦ă"mÈé3nu¹7ĊĆë¿3ÚÀ³"ÊÑûÂ!3ì

2005 ! PDP !dìú#

0&ÊÑ( CHMAKO ?GDJNI>OB) ċ!.ý61Ô¯´Á!

3%"øä¥Þ"`ânu¹7öf3-!^¿Ô¯"´ÁÊÑ!ý3Täìú¡k|[zą#Ô¯Ý!ý3¥

3ÅÃ¹!

3

T!ËÊÑFL@;=C/YT"ÎÊÑ!ì3P¦ àÊÑ#ËN¿Î"Sü!3ÊÑFL@;=Cw"ìú

7èõ0Ü83"-øìúQ"Ā27¾83á}Â½3<M/ÙÀ!Ö

ËÎ

"À³!#ãÞZÍ#gÄ7.1oÞy7Ą"ûÂ7Ð°Ã!ßP¦Ô¯!ý#)8"ãÞZÍ#IA=7÷3aw!2PÏć"«jnu¹

º4

Ç



TB 9H:9MA#"CHMAKO?GDJNI>OBx$43eù!rb3!#Ă!þ14Øj7íÊÑ7

u6ô3ä- àeù®Ó¸å43q¼"æ©3"-!#CHMAKO?GDJNI>OB"ÊÑF

R<7:B2ĎĥYÝ/£Ăďĝ±u2üäæ!

/"ďĝ#ijĚğûĠÜÞ"MAP+Ô~Å×
#W}÷/¼

#-wûĠÜ!

iÝďĝü/|.ò'!,.£Ă

#ËÛĩđÝĕÇ2Ė/

|.ò'#¹![/ÁóÄ"ËÛ¿ġ2¶Ĕġ*
"ġ"ģ.2-l/Üă2»ã#¶ºġ&!áõ/)!#µ¡#æwû

¹!ÜăÎ'"·vÑ!£ĂøĉĪ!´±2ü%/öó Č( ½ì 6 ëûsĠÜ"·MAP-" ¯ð)Æî0/)äâè#Ď*"éÏØbN5HNO"ěn!
óÄú!/¾·"męaÝ«ÉÖÑÖÕ"àčÕąßĄĕ/éÏØÖ©2mÂÀ_]g«}÷!

ęa­q¬ý

"GB!,.GBóÄú"äV(Jansen and Yu, 2006; Kana and Mizrahi,2004; Kaufmann et al., 2005; äâèmĜĘ©0Z

ĕÇ"Ċñ#oÿ A zÐ)0#1990 ^!êþÖâèª/3QP9U§ÃÚâèª(NIH/NIAID)67P8LTBN=B
EU

"ZĂ,.}÷!
ďĝ±uâèĝbüGBóÄ"âèĠÜ!/ďĝ±uIR;NL!

×«!g/ÓÌ#ĞĈ»,!ÓÌ#k¢v.",#ôÍr¨¤°ôÝ/\ºóÄËÛû"F5IN5S#ėy 40 ġ¾*f/0#ÔĠÜY"vÑhb",x¶/#eĀvÑ"Ò2ßÝâè!Ģd/óÄËÛûĠÜ")"X×Þ ü/âè"Ê!Ģ/âèĠÜ"WĐ!Ģ/å`"ċč*/ėy¶ġĨ'-0ī&*ïāû`å"¶å ĦpTĦ²JU=óÄû"ĠÜ$"®ď!
;N:?T=K=:N5Sí"c!³1."Ù(DEP@4=3=BN>C8/)&¶å"āû`å#©t2{)/ÔøÅJU=óÄ"âèĠÜĪY"óÄËÛû"eĀ 6 ç" 3 ç#pßÝĠÜ0*"/&È / Ē £Ă¦ėy¶*-0ùv!*"âèĠÜ!
/

/ÕÝ

1-|.ò(%wûćĆ"¸+¥ēħ&.óÄËÛûĕÇ2/

Ĥ*&

h 3Ç­

&(V£)²<0>?0Aº4?=­tgw¾°rÁ)²zÅAÆ²¾>@5139`(¬.

)¶²L¦;02KzÅBÆ-³)
TSÈ ªi¥¨¶²p\LÅPhRMAÆ¹Åhttp://www.phrma.org/ÆÅCÆ­tgw DALYÅÂm¹{dqÆ)G¢ÂmºTSÈ WHOGNPkc 2004Åhttp://www.who.int/whr/2004/en/09_annexes_en.pdfÆ
ÅEÆ4?=D8B7-!#³ TSÈ PhRMAÉ§TSÈ WHOÆ©C¼·f¾j­sÃ-F*)<0>?0A)®b¢|#[UzYb)(Glickmann et al., 2006)In´i)²W<0>?0Az!o*­)o)+OµYb`(¬.);02K%¶²L¦zÀ'*)

-_)(h 3 ^)TB /?0/A6<B9:B"y±*&(~X',*)²- 2010 q!R|§²-`(Q*- 2015 q!Z²e ¡ ½  )     )  (TB/ ? 0 / A 6 q  k c  2004 Ê 2005

http://www.tballiance.org/downloads/2005%20annual%20008_6b.pdf)J}j<0>?
0A¤-l)-»$1 ¼·fÄj¾)Ea¯)

HOµYbu¿)$)³ 4 ¾HOµ²M¿)I·v-!#) (]CYb¿)¸«xk³ 3$^)`ÛÙµ!z£!mrµ,±º-¸w]»/.ÙsÌÓëÈ0ªÁ.",.ùZµ*±ºµ0ñÀ.

D2F49L6AKLÝ,/.+

uø0º.qÔ".

!¯¶~/µæI"WÒ!

.(Ginsburg et al., 2006a; Moghazeh et al, 1996)ü¯Oé!Ì×ÂÁµ0Ð
:3IJ6AKL TMC-207(¸wÕb/.Üáú!ÊT a ¬ör0g. ATP ² pH !QxÚ0.mrµ!O^".).!mrµ" ATPasee|©èûlµG>J!RòÍ¥"®¿¡ò0 2 MÅÏ.qÔ+-\».qÔ.0Çt.(Andries et al, 2005)

ÙhB4EH4L!fÁe¤o,/),,Í¨®¿Ù!ÙñÀ¸wÕ

"C?yÍ¨.\»0ÂÁ!.,/,!mrµ"°À¬ö.)

"Í¨×!º}çÜð·Ù`Û)¢£¶~/)ð.Ì×0­Ôi!(ì#/)!

ÉÆp0ñQq«.ïÜªÁµ{®¿¡\».mrµ0¶~.

.´Í¨!ó_Ñ!Ý"OÖ.Xä½.Ì×!&&V÷v"¦Ñ![dc}qÔ.âå

.Xä*S!a¾ô0º

/%

;7IN@L8

(Andries et al, 2005; Stover et al, 2000)Í¨®¿
ò0ÅÏ.(r¹Á¯+-k¥!.Ù0r¹Á

$.(Ì×ßÞ.Üû&-]º¹Á¼ÃU\».+.!O^YÄnó_.

à/íË4=75LîI3N<õh!ã§.!íË0g.
.mrµ"Î!×0­1!mrµ"°À¡/.¸w!B4EH4LP

ð.×0ªÁ.!(­×\»".

\»"!(¸wñÀR!Ù"®¿¡ò0 23 M
,!Ù"{"&Øj0),."®¿¡ò0êò."',/.

ÅÏ.



.%
³×/&ÅÏ.

½ 4. 5<9B TB»KN/L22INBÊ$&WeiÍPÁW¤E.=6D)¸

[(±¹^Û'

$i¡ªÄÃÐq×w?<³·S£ªÆXQË'|'µºn®£tPd'"º£V]£sÕÎ'«ªY¾uÅ!lØÇÚ'bª»«ª&'£VetBJ75^rªQ­vÝ"»¬°Ô©\VH51

#%!?<mµºzp$&Z("»ª'£Ý!&¿»Ê'Þ`|'¦'¢o)­'"µ¨ÆX)¼À'%µº)ºMÖg'ÐÀTÈBJ75Q­v)y'

#À   '  R ¥  § ¨  x  ' q   '   , = 4 + 8 A(http://www.gcgh.org/subcontent.aspx?SecID=403)O¢3,:Ék¯«ªu)«ª}«ªn»Ô©BJ2GD)v¼'¶^r´ÌÕ'¬°ÊÒa)¼'
2 «i¡ªf»jÄÃ
'cF;I'Ðq×wÙ{b»_ª'?<mµºÓ¶n®ªÏUªQË'~Â('# 1 TÈ´Ì->I0N©£ÑÜ²heC1J@*N

0E#haE}\«£'¦

iHwox^((Shi et al., 2005; Darwin et al., 2003; Sassetti et al., 2003; Schnappinget et al., 2003;
Rachman et al., 2006)

(%w&d'"¥A[>ugM$]

>ugM)¡r

Zb>'!npmªZ¬&x^'(X 4 )Pv)m?MSw1,;=7<-G~Rw

86Yq@}|tm$&_{(''?V­ 1 wr#¥Ag]F¨fLª`'j©kJ)C''.+5Uoxqmª)B¤')m+7/*39)

(qB¤+7/*39the “TB drug accelarator” initiative) (%§z)!"$cW
UOyKINF=2=/4:e'§D}T®l¢Q&!.+5T((% %ZsDt«;

4.

抗PDP

(Moran etal., 2005)

PDPGm++³¥¸Î¦P-$Ñws¨U+Q

+º¸R­(+Å,+`*²%

58<ÒF82/Ê~z¡
BE1J+o\/+gÎ¦O^aÎ¦BI98MÄ+P-|.¦¼/¼X¶¸d£¾a

Ó*+viÌ½_S©t+')!,)¹e,¥b}]§Ô%+Ô%),¤&ZÐ¸«+,(*h¬®pªÁ/¯¨§`*²%j+uÆ{»~+kf±º¸£·c/Ã+vipRº¸£¸Î¦y

EJ8HL7D=GKF6L:a,!}ÇÈ§_¸dÀ¿"0BIL:N/TÈ+¸Î¦A1°Î¦r+Â/_¸d£§0BIL:

4?C¹@18GLB;<K82FL>J3X ´³pÈ),¤«°É¢,+#Ï+aln§_¸dÀ¿q),+-,$$³(¤¸x[Wµ{»+<+V§ËÍÉY`*²%